Capstone Investment Advisors, LLC Amicus Therapeutics, Inc. Transaction History

Capstone Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $504,491 - $932,205	-37,453 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $193,350 - $238,350	15,000 Added 66.81%	37,453 $529,000
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $157,708 - $279,282	17,800 Added 382.55%	22,453 $339,000
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $517,219 - $743,330	-69,147 Reduced 93.7%	4,653 $45,000
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $80,200 - $132,500	-10,000 Reduced 11.93%	73,800 $592,000
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $283,864 - $372,960	25,900 Added 44.73%	83,800 $1.05 Million
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $581,316 - $805,968	57,900 New	57,900 $787,000

312

311M

467K

515K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.55B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.